Advancing FA Treatment: Exploring the Pharmacology of Neonatal Cardiac Progenitor Cells for Cardiac and Neuroprotection
NRF2 and MAO-Ai therapy to improve cardiac health and prevent arrhythmias in Friedreich’s ataxia
Developing the novel investigational mitochondrial therapeutic SBT-589 for Friedreich’s ataxia
Treatment of Friedreich’s ataxia using novel ferroptosis inhibitors
Testing the efficacy of dietary butyrate in ameliorating ataxic symptoms in Friedreich’s ataxia mouse models
Cardiac benefit of drugs that stimulate Nrf2 and HCA2 pathways in Friedreich’s ataxia